Detection of early changes in the coronary artery microstructure after heart transplantation: A prospective optical coherence tomography study.

BACKGROUND Optical coherence tomography (OCT) enables in-vivo cardiac allograft vasculopathy (CAV) microstructure characterization. Early coronary artery microstructure changes after heart transplantation (HTx) may provide valuable mechanistic information regarding CAV development. Our in this study was to describe and characterize changes in the coronary artery microstructure during the first year after HTx using serial OCT scans. METHODS Twenty-six patients were enrolled at routine baseline coronary angiography 3 months after HTx. Coronary OCT scans were performed on all 3 major vessels at baseline and were repeated 12 months after HTx. We contoured the vessel layers for absolute and relative measurements. Lipid plaques, calcified plaques, layered fibrotic plaques (LFPs) and bright spots were analyzed by delineating circumferential borders and measuring angulation of total circumference. RESULTS A total of 8,789 frames from 71 vessels were analyzed after 3 and 12 months (vessel length 79 ± 24 mm vs 82 ± 23 mm, respectively, p = 0.39). Mean intima area increased by 20% from 3 months to 12 months (1.6 [1.2 to 2.7] mm2 vs 1.9 [1.3 to 3.2] mm2, p < 0.0001). Mean lumen area decreased by 2% (9.1 [7.5 to 11.6] mm2 vs 8.9 [6.9 to 10.9] mm2, p < 0.01). LFPs showed an almost 5-fold increase at follow-up (1.0% [0% to 6.5%] vs 4.8% [0% to 24.5%], p < 0.0001). Bright spots were also detected more frequently at 12 months (0% [0% to 2.8%] vs 0.8% [0% to 6.8%], p < 0.001). We found no significant difference in extent of lipid plaque (p = 0.78) or calcified plaque (p = 0.37) during follow-up. The intima area change and LFP progression during follow-up correlated strongly (r2 = 0.51, p < 0.0001). CONCLUSIONS Early CAV formation during the first year after HTx is characterized by a pronounced intima layer thickening strongly associated with LFP progression. In contrast, the extent of lipid plaque and calcifications remained stable. LFP formation may be a key mechanism in CAV.

[1]  L. Lerman,et al.  Repeated episodes of thrombosis as a potential mechanism of plaque progression in cardiac allograft vasculopathy. , 2013, European heart journal.

[2]  Josef Stehlik,et al.  The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  R. Starling,et al.  International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  C. Morrell,et al.  Small cells, big effects: the role of platelets in transplant vasculopathy , 2013, Journal of Thrombosis and Thrombolysis.

[5]  G. Gerosa,et al.  Coronary Flow Reserve by Contrast‐Enhanced Echocardiography: A New Noninvasive Diagnostic Tool for Cardiac Allograft Vasculopathy , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  M. Fishbein,et al.  Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  J. Kobashigawa Potential immunosuppressive effects of statins * , 2008, Pediatric transplantation.

[8]  K. Bouchelouche,et al.  Noninvasive Detection of Cardiac Allograft Vasculopathy by Stress Exercise Echocardiographic Assessment of Myocardial Deformation. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  D. Pascual-Figal,et al.  Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy. , 2012, The American journal of cardiology.

[10]  Bingren Gao,et al.  Simvastatin combined with aspirin increases the survival time of heart allograft by activating CD4(+)CD25(+) Treg cells and enhancing vascular endothelial cell protection. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[11]  F. Prati,et al.  Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  L. Sade,et al.  Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  E. Tuzcu,et al.  Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. , 2005, Journal of the American College of Cardiology.

[14]  G. Gerosa,et al.  Coronary Flow Reserve by Transthoracic Echocardiography Predicts Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  H. Bøtker,et al.  The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One‐Year Results of a Scandinavian Randomized Trial , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  J. Tobis,et al.  Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients. , 2006, Journal of the American College of Cardiology.

[17]  M. Weyand,et al.  Clopidogrel reduces the development of transplant arteriosclerosis. , 2006, The Journal of thoracic and cardiovascular surgery.

[18]  F. Fallani,et al.  Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  Eloisa Arbustini,et al.  Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. , 2010, European heart journal.

[20]  S. Høyer,et al.  The long‐term influence of repetitive cellular cardiac rejections on left ventricular longitudinal myocardial deformation in heart transplant recipients , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[21]  R. Starling,et al.  Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  M. Kass,et al.  Diagnosis of graft coronary artery disease , 2007, Current opinion in cardiology.

[23]  J. Tobis,et al.  Vascular remodeling 1 year after cardiac transplantation. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  B. Bergmark,et al.  Early aspirin use and the development of cardiac allograft vasculopathy. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  W. Kremers,et al.  Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  Amir Lerman,et al.  Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. , 2013, European heart journal.

[27]  C. Toma,et al.  Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study). , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  T. Nazif,et al.  Optical Coherence Tomographic Evaluation of Transplant Coronary Artery Vasculopathy With Correlation to Cellular Rejection , 2014, Circulation. Cardiovascular interventions.

[29]  E. Arbustini,et al.  Multiple coronary thrombosis and allograft vascular disease. , 1998, Transplantation proceedings.

[30]  L. Lerman,et al.  Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[31]  Jouke Dijkstra,et al.  Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT. , 2017, JACC. Cardiovascular imaging.

[32]  Akiko Maehara,et al.  Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. , 2012, Journal of the American College of Cardiology.

[33]  A. Huisman,et al.  Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study. , 2014, Atherosclerosis.

[34]  G. Weisz,et al.  Detection and imaging of cardiac allograft vasculopathy. , 2013, JACC. Cardiovascular imaging.

[35]  A. Yeung,et al.  Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. , 2005, Journal of the American College of Cardiology.